2002
DOI: 10.1016/s0021-9150(01)00750-x
|View full text |Cite
|
Sign up to set email alerts
|

Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
29
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(32 citation statements)
references
References 47 publications
3
29
0
Order By: Relevance
“…We also showed that both hydrophilic and lipophilic statins suppress molecular expression, including tissue factor and plasminogen activator inhibitor-1, by depletion of cellular geranylgeranylpyrophosphate (GGPP) 16,[26][27][28] . Taken together with other reports [29][30][31] , our previous study clearly demonstrated the exact mechanism of the pleiotropic effect that statins rapidly blocks the activation of unprocessed GDP-RhoA by inhibiting geranylgeranylation 9) .…”
Section: Discussionmentioning
confidence: 94%
“…We also showed that both hydrophilic and lipophilic statins suppress molecular expression, including tissue factor and plasminogen activator inhibitor-1, by depletion of cellular geranylgeranylpyrophosphate (GGPP) 16,[26][27][28] . Taken together with other reports [29][30][31] , our previous study clearly demonstrated the exact mechanism of the pleiotropic effect that statins rapidly blocks the activation of unprocessed GDP-RhoA by inhibiting geranylgeranylation 9) .…”
Section: Discussionmentioning
confidence: 94%
“…It has been revealed that Rho/Rho kinase is associated with the generation of TF (Nagata et al, 2002) and can regulate the expression of TF. The Rho/Rho kinase signaling pathway includes Rho protein, Rho kinase, myosin phosphatase, etc.…”
Section: Discussionmentioning
confidence: 99%
“…RhoA proteins are modulators of gene expression, adhesion, and migration of activated macrophages, which also play critical roles in inflammatory signal pathways, such as those required for activation of NF-B (31). In addition, inhibition of Rho/Rho kinase proteins down-regulates the synthesis of TF by cultured human monocytes, and statins (known immunoregulatory and antithrombotic compounds that are now being experimentally tested in APS patients) suppress the synthesis of TF mediated by inhibition of Rho activity (32). Agonists reported to activate Rho proteins in vascular cells include thrombin, endothelin 1, and angiotensin.…”
Section: Discussionmentioning
confidence: 99%